Multivariate meta-analysis (MMA) is a powerful tool for jointly estimating multiple outcomes' treatment effects. However, the validity of results from MMA is potentially compromised by outcome reporting bias (ORB), or the tendency for studies to selectively report outcomes. Until recently, ORB has been understudied. Since ORB can lead to biased conclusions, it is crucial to correct the estimates of effect sizes and quantify their uncertainty in the presence of ORB. With this goal, we develop a Bayesian selection model to adjust for ORB in MMA. We further propose a measure for quantifying the impact of ORB on the results from MMA. We evaluate our approaches through a meta-evaluation of 748 bivariate meta-analyses from the Cochrane Database of Systematic Reviews. Our model is motivated by and applied to a meta-analysis of interventions on hospital readmission and quality of life for heart failure patients. In our analysis, the relative risk (RR) of hospital readmission for the intervention group changes from a significant decrease (RR: 0.931, 95% confidence interval [CI]: 0.862-0.993) to a statistically nonsignificant effect (RR: 0.955, 95% CI: 0.876-1.051) after adjusting for ORB. This study demonstrates that failing to account for ORB can lead to different conclusions in a meta-analysis.
翻译:多变量元分析(MMA)是联合估计多种结果治疗效果的有力工具。然而,MMA结果的有效性可能因结果报告偏差(ORB)或有选择性报告结果的研究趋势而受到损害。直到最近,ORB一直没有得到充分研究。由于ORB可能导致有偏差的结论,因此纠正影响规模的估计数并量化其在ORB的存在情况下的不确定性至关重要。我们为此制定了一个贝叶西亚选择模型,以调整MMA的ORB。我们进一步提议了一项量化ORB对MMA结果的影响的措施。我们通过对Cochrane系统审查数据库748双轨元分析结果的元评价来评估我们的方法。我们的模型受到以下因素的驱动并应用于对医院重感应和心脏病病人生活质量干预措施的元分析。在我们的分析中,医院复诊的相对风险从大幅下降(RR:0.931,95%的置信度间隔[CI]:0.86-0.09.993)到这一统计性分析结果(IRA:0.95)之后的REM-RM),这一模型可以显示这种非结果。